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Abstract
Objective: To conduct an overview of alcohol-related
health consequences and to estimate relative risk for
chronic consequences and attributable fractions for
acute consequences. Methods: Identification of alcohol-
related consequences was performed by means of re-
viewing and evaluating large-scale epidemiological
studies and reviews on alcohol and health, including epi-
demiological contributions to major social cost studies.
Relative risks and alcohol-attributable fractions were
drawn from the international literature and risk estimates
were updated, whenever possible, by means of meta-
analytical techniques. Results: More than 60 health con-
sequences were identified for which a causal link be-
tween alcohol consumption and outcome can be as-
sumed. Conclusions: Future research on alcohol-related
health consequences should focus on standardization of
exposure measures and take into consideration both
average volume of consumption and patterns of drink-
ing.
Copyright © 2001 S. Karger AG, Basel
Introduction
Over the last decade, research on alcohol-related health
consequences has rapidly expanded. Generally, studies
assessing such consequences distinguish between chronic
(e.g. cancers) and acute (e.g. accidents) outcomes [1]. Such
a categorization seems to be practical as these two catego-
ries could be grossly distinguished by E-codes versus all
other codes in the ICD-9. In addition, chronic conse-
quences mainly related to long-term alcohol use are, in
most cases, associated with the volume of drinking and
assumed to be cross-culturally stable. In contrast, acute
consequences were seen to be more influenced by drink-
ing pattern (such as heavy episodic drinking) and cultural
factors [2]. As a consequence alcohol-attributable frac-
tions of chronic consequences were often derived by indi-
rect methods which combine cross-culturally pooled
meta-analytic risk estimates with country-specific preva-
lence of volume-oriented consumption categories. On the
other hand attributable fractions of acute consequences
influenced by the cultural environment and drinking pat-
tern were usually assessed by direct methods (e.g., case
counts of police records of drinking and driving [3]). Such
a gross classification, however, is overly simple. For
example, there is increasing evidence that (a) some
‘chronic’ consequences are more or at least evenly related
to heavy episodic drinking [4, 5]; (b) some ‘acute’ conse-
quences such as suicides may be differently related to
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Table 1. Exclusively alcohol-related conditions
ICD-9 Disease
291 Alcoholic psychoses
303 Alcohol-dependence syndrome
305.0 Alcohol abuse
357.5 Alcoholic polyneuropathy
425.5 Alcoholic cardiomyopathy
535.3 Alcoholic gastritis
571.0–571.3 Alcoholic liver cirrhosis
790.3 Excess blood alcohol
980.0, 980.1 Ethanol and methanol toxicity
both chronic heavy drinking, and acute episodes of intoxi-
cation [6, 7] or the association may differ across cultures
ranging from negative to positive association [8], and
(c) some chronic consequences can be assessed by direct
methods (e.g. alcoholic dependence syndrome).
To summarize the state-of-the-art in the field of alco-
hol-related consequences, we compiled and evaluated re-
cent scientific evidence. First, comprehensive overviews
of the relationship between consumption and morbidity/
mortality, often undertaken as epidemiological input to
social cost studies, were compared [9–16]. Completeness
was also verified with other general overviews of health
conditions related to alcohol consumption [17–20]. Since
these studies differed greatly in their attribution of alco-
hol causality to health conditions, we set out to: (1) search
for new evidence to clarify causality in relation to condi-
tions on which existing mortality/morbidity studies were
discordant; (2) suggest an up-to-date list of alcohol-related
health conditions, and (3) offer pooled estimates of rela-
tive risks (RRs) or attributable fractions for those conse-
quences, which were considered established.
Methods
Identification of Consequences
Identification of alcohol-related consequences was performed by
means of reviewing and evaluating large-scale epidemiological stud-
ies on alcohol and health, including epidemiological input into major
social cost and comprehensive reviews [9–21]. Scientific papers were
collected primarily from the peer-reviewed, international literature.
Following accepted guidelines established in the first major review
[13], evidence was assessed according to methodological criteria such
as quality of studies, relevance and strength of evidence, as well as
biological plausibility. All conditions were included in the final list
(tables 1–4), for which the evidence for a causal relationship with
alcohol was conclusive [for more detailed information about the pro-
cess of reviewing and evaluating the empirical evidence see, 22].
Relative Risks and Attributable Fractions
Some conditions such as alcoholic psychosis or alcohol depen-
dence syndrome are, by definition, causally related and wholly attrib-
utable to alcohol (table 1). For most conditions, however, alcohol is a
contributory rather than a sufficient cause [23]. Thus, a measure of
the fraction of cases attributable to alcohol (alcohol-attributable frac-
tion, AAF) is needed for each of these conditions. To determine
attributable fractions a counterfactual scenario is required, that is a
description of an alternative distribution of exposure, to which the
actual distribution is contrasted [24]. The prevailing counterfactual
scenario for alcohol as a risk factor is abstention (e.g. no alcohol at
all), although other scenarios such as moderate consumption have
been applied as well [3, 13]. The AAF for chronic conditions are
usually determined indirectly by combining RRs and prevalence
data at different levels of consumption [for a detailed description of
the method see, 10]. For the purpose of the present study, only RRs
will be presented. RRs were drawn essentially from English et al.
[13]. Risk estimates were updated whenever possible (e.g. for female
breast cancer, diabetes, coronary heart disease) by inclusion of stud-
ies appearing since English et al. [13]. Pooling of several risk esti-
mates was performed by means of precision-based weighting [13].
Methods and results of the pooling-procedure (meta-analysis) have
been described in more detail elsewhere [22].
In contrast, the AAFs for acute consequences such as accidents
and injuries are usually determined directly by assigning empirically
given cases to alcohol whenever the responsible individual was under
the influence of alcohol at the time of the event. To cite an example,
road accidents are attributed to alcohol whenever the accident-
responsible driver tested positive for alcohol (e.g. at a blood alcohol
concentration, BAC, of 10.05%). As RR estimates are usually rare,
for the purpose of the present study AAFs from the international lit-
erature [10, 13, 22, 25] were compared.
Results
To structure the presentation and discussion of results,
we suggest that alcohol-related health consequences be
categorized as follows: (1) chronic consequences, such as
wholly alcohol-attributable consequences, cancer (neo-
plasm), cardiovascular disease, liver cirrhosis, effects of
prenatal alcohol exposure and other chronic harms;
(2) benefits of alcohol consumption, such as cardiovascu-
lar disease and other conditions, and (3) acute conse-
quences, such as accidental injury and poisoning, suicide,
interpersonal violence and assaults.
Chronic Consequences of Drinking
Wholly Alcohol-Attributable Consequences
With regard to the attribution of alcohol-relatedness,
most unproblematic are those consequences that, by defi-
nition, are wholly alcohol-attributable (AAF = 1; table 1).
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More complicated to assess are those consequences
where alcohol plays a contributory role. These will be pre-
sented and discussed cause-specifically in the following
sections.
Cancer
Oropharyngeal, Esophageal and Liver Cancer: Alcohol
has consistently been related to the risk of cancer of the
mouth (lip, tongue), pharynx, larynx, hypopharynx,
esophagus and liver [1, 13, 17–19, 21]. The relationship
between the average volume of alcohol consumption and
cancer is usually characterized as being monotonically
increasing but this may be partially an artifact of the
methods [18]. Evidence for these cancers has accumu-
lated from case-control and cohort studies. Recently,
much emphasis has been put into the biochemical mecha-
nisms to explain the carcinogenic behavior of alcohol in
laboratory studies [19].
Female Breast Cancer. Much research has been con-
ducted over the last decade on female breast cancer. In
overviews prior to 1995, it was most often concluded that
evidence of a causal relationship with alcohol was insuffi-
cient [26, 27]. However, recent studies and reviews have
shown that not only hazardous or harmful but even mod-
erate alcohol consumption can cause female breast cancer
[9]. A meta-analysis by Smith-Warner et al. [28] found a
clear linear relationship over the whole continuum of con-
sumption. Other original studies supported this finding
[21, 29–34]. In contrast to the weight of evidence, Zhang
et al. [35] concluded from their investigation that moder-
ate intake did not increase the risk of breast cancer, and
that low drinking was associated with a protective effect.
This finding, however, appears to be a notable outlier [36]
and, so far, has not been corroborated by any further
study. Recent studies focus on plausible biological mecha-
nisms including alcohol’s effect on hormones and tissue,
alcohol’s contribution to the initiation and progression/
promotion of breast cancer, but also alcohol’s interaction
with nutritional factors [19, 37].
Stomach, Pancreas, Colon, Rectum and Prostate Can-
cers. Furthermore, many recent research projects have
investigated whether cancers of the stomach, pancreas,
colon, rectum and prostate are alcohol-related. Overall,
evidence for a causal relationship between alcohol and
cancer of these sites, if any, was weak and inconclusive
[37–50]. On prostate cancer, again most studies did not
report observing an increased risk [51–54], whereas two
cohort studies [55, 56] and one case-control study [57]
reported a small increased risk in men who consume even
moderate amounts of alcohol. Overall, evidence for a cau-
sal relationship between alcohol and cancer of the stom-
ach, pancreas, colon, rectum and prostate is so far not
conclusive.
Major Salivary Glands, Ovarium, Endometrium and
Bladder. Moreover, it has been hypothesized that alcohol
might constitute a risk factor for cancer of the major sali-
vary glands [58, 59], ovarium, endometrium [43, 60–62],
and the bladder [43, 63–65]. For each of these sites,
results were either scarce or heterogeneous, or the effects,
if any, were found not to be statistically significant.
Cardiovascular Disease
The role of alcohol, as both a risk and protective factor
for cardiovascular disease has been studied extensively in
the past decade. As far as coronary heart disease (CHD) is
concerned, the effect of moderate alcohol consumption
clearly is a beneficial one. Furthermore, most studies sug-
gest that low-level consumption equally offers some pro-
tection against stroke, particularly ischemic stroke. The
benefits of alcohol consumption on both stroke and CHD
are therefore discussed in the following section. In con-
trast, hypertension and other cardiovascular disorders
such as cardiac arrhythmias and heart failure as well as
ill-defined descriptions and complications of heart dis-
ease are adversely affected by alcohol [4, 66–69]. The
weight of evidence suggests that hazardous and harmful
levels of consumption cause hypertension in both men
and women [13, 70–74]. Low-level intake, however, was
not associated with hypertension in men, while it confer-
red a small protective effect in women [13, 72].
Liver Cirrhosis
Alcohol is regarded as the leading cause of cirrhosis in
established market economies [13, 75–77]. Whereas the
association with alcoholic liver cirrhosis is clear with all
cases being attributable to alcohol, debate remains wheth-
er this equally applies to unspecified liver cirrhosis. Sever-
al authors contend that, empirically, it is extremely diffi-
cult to separate alcoholic from unspecified liver cirrhosis
and that the term ‘unspecified liver cirrhosis’ is applied
when no specific etiological factor is reported or identified
[13]. Research in the USA indicated that an appreciable
proportion of cirrhosis deaths without mention of alcohol
was in fact attributable to alcohol [78]. On the other hand,
to apply AAFs of liver cirrhosis to other countries can be
extremely misleading. In many countries (e.g. China or
India) liver cirrhoses are caused by other factors such as
viral infections. The corresponding AAFs have been
shown to vary between less than 10% (China) and 90%
(Finland) [1].
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Table 2. Chronic alcohol-related health effects with relative risks
Disease ICD-9
intake
RR
low
females males
hazardous
females males
harmful
females males
140, 141, 143–146, 148, 149, 230.0 1.45 1.45 1.85 1.85 5.39 5.39
Esophageal cancer 150, 230.1 1.80 1.80 2.38 2.38 4.36 4.36
Liver cancer 155, 230.8 145 1.45 3.03 3.03 3.60 3.60
Laryngeal cancer 161, 231.0 1.83 1.83 3.90 3.90 4.93 4.93
Female breast cancer 174, 233.0 1.08 – 1.30 – 1.66 –
Epilepsy 345 1.34 1.23 7.22 7.52 7.52 6.83
Hypertension 401–405 0.85 1.02 1.27 1.43 1.79 2.05
Cardiac arrhythmias 427.0, 427.2, 427.3 1.51 1.51 2.23 2.23 2.23 2.23
Heart failure 428–429 * * * * * *
Esophageal varices 456.0–456.2 1.26 1.26 9.54 9.54 9.54 9.54
Gastroesophageal hemorrhage 530.7 n.a. n.a. n.a. n.a. n.a. n.a.
Unspecified liver cirrhosis 571.5–571.9 1.26 1.26 9.54 9.54 9.54 9.54
Acute and chronic pancreatitis 577.0, 577,1 n.a. n.a. n.a. n.a. n.a. n.a.
Spontaneous abortion 634 1.20 – 1.76 – 1.76 –
Low birth weight 656.5 0.89 0.89 1.62 1.62 1.62 1.62
Psoriasis 696.1 1.58 1.58 1.60 1.60 2.20 2.20
Prematurity 764 0.93 0.93 1.36 1.36 1.36 1.36
Intrauterine growth retardation 765 0.99 0.99 1.68 1.68 1.68 1.68
n.a. = Relative risks not applicable because the attributable fraction was obtained by a direct method: 530.7 = 0.47; 577.0 = 1.00; 577.1 = 0.84.
* Heart failure-attributable fraction determined indirectly from other circulatory diseases.
Effects of Prenatal Alcohol Exposure
Today, there is ample evidence that alcohol consump-
tion during pregnancy is related to various risks to the
fetus which include gross congenital anomalies and fetal
alcohol syndrome [79–92]. Fetal alcohol syndrome has
been characterized as a continuum, with minor physical
malformations at one end and serious neurobiological dys-
functions including mental retardation on the other end
[93]. The prenatal teratogenic effects of alcohol also in-
clude lethal consequences such as spontaneous abortion,
low birth weight, fetal damage and premature/intrauterine
growth-retardation [62, 94, 95] even at low levels of aver-
age consumption during the first trimester of pregnancy.
Other Chronic Conditions
Other risks of alcohol consumption currently discussed
in the literature are epilepsy [96–98], acute and chronic
pancreatitis and psoriasis. Whereas for pancreatitis the
causal role of alcohol seems to be clear, Skinazi et al. [99]
and Amman et al. [100] contend that the discrimination
between acute and chronic pancreatitis is not justifiable
since the overwhelming majority of patients presenting
with acute pancreatitis have at the same time an underly-
ing chronic pancreatitis [101, 102]. On psoriasis, our
search did not yield any recent studies. English et al. [13]
found that the results of the pooled estimates were consis-
tent with a moderately strong and statistically significant
effect.
Given that the chronic consequences discussed above
are caused not only by alcohol but by other factors as well,
it is necessary to estimate the likelihood of alcohol causa-
tion (by means of RRs). Table 2 summarizes the evidence
on alcohol-related chronic consequences and presents the
respective RRs at different levels of consumption.
Benefits of Alcohol Consumption
Cardiovascular Disease
CHD is one of the leading causes of death in estab-
lished market economies and developing countries [103].
At the same time, the most important health benefits of
alcohol have been found in the area of CHD at low to
moderate levels of consumption [18, 72, 104–111]. Only a
few studies have failed to substantiate this association in
men [112] or women [113, 114]. Some studies found that
alcohol may offer protection against CHD not only at low
to moderate intake but across the continuum of alcohol
consumption [71, 115–119]; they nevertheless show that
most of the protective effect is gained at low levels of con-
sumption such as one drink every other day. Further-
more, the relationship appears to be associated with par-
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
7/
7/
20
16
 4
:0
4:
23
 P
M
Diabetes
Alcohol-Related Health Consequences Eur Addict Res 2001;7:117–127 121
Table 3. Beneficial alcohol-related health effects with relative risks
Disease ICD-9
intake
RR
low
females males
hazardous
females males
harm
females males
250 0.92 0.99 0.87 0.57 1.13 0.73
Coronary heart disease 410–414 0.82 0.82 0.83 0.83 0.88 0.88
Stroke 430–438 0.59 0.69 0.51 0.95 7.72 1.79
Cholelithiasis 574 0.82 0.82 0.68 0.68 0.50 0.50
ticular patterns of drinking [4, 120, 121]. The biological
mechanisms explaining the protective effect of alcohol
are, for example, increased high-density cholesterol levels
and antithrombotic effects [1, 122–125]. To date, the cru-
cial point in assessing the effect of alcohol on CHD
remains hazardous consumption [118].
Other Conditions
Cerebrovascular disease (stroke) comprises two essen-
tial subtypes which are differently affected by alcohol. As
far as ischemic stroke is concerned, the predominant type
of stroke, the weight of evidence including biological
mechanisms suggests similar effects as for CHD, namely
that low to moderate consumption may offer some protec-
tion [71, 74, 105, 116, 126–130]. Concerning hemorrhag-
ic stroke, the weight of evidence suggests an increase in
risk even at low levels of consumption [126, 131–133].
Furthermore, alcohol may offer some protection
against diabetes and cholelithiasis (gallstones). The Aus-
tralian meta-analysis by English et al. [13] concluded that
there was some evidence that alcohol may protect against
the onset of diabetes. Since then, the findings from a
cohort of more than 40,000 male health professionals
showed that moderate alcohol consumption may decrease
the risk of diabetes, perhaps through the effects of alcohol
on insulin sensitivity [134]. In addition, findings from the
British Regional Heart Study indicated a protective effect
[135]. Further, in a follow-up of men enrolled in the US
Physicians Study a marked negative association of inci-
dent diabetes with alcohol consumption was shown [136].
In a recent prospective study, a U-shaped association
between alcohol and type-II diabetes was found [137].
However, Kao et al. [138] found that, in women but
not in men, there was evidence (based on small numbers)
of an inverse relationship between alcohol consumption
and the risk of diabetes. Indeed, men consuming more
than 21 drinks per week were at increased risk of diabetes.
A protective effect of moderate alcohol consumption
against diabetes may be mediated through the effects of
alcohol on glucose tolerance and insulin resistance. Mod-
erate alcohol drinking has been shown to increase insulin
sensitivity [139–141] and lower insulin resistance [142],
even in young adult drinkers [143]. In summary, there is
growing evidence from cohort studies that moderate alco-
hol consumption reduces the risk of diabetes and a plausi-
ble underlying biological mechanism has been identified.
With regard to cholelithiasis (gallstones) there is some
evidence that alcohol may offer some protection against
gallstones [13, 72]. These findings have been substan-
tiated by recent large-scale cohort and case-control studies
which reported an inverse relationship [144–147]. Ta-
ble 3 gives an overview of diseases on which alcohol has
potentially beneficial effects.
Acute Consequences
Accidental Injury and Poisoning, Suicide,
Interpersonal Violence and Assaults
Alcohol use has been associated with increased risk of
traumatic injury in a variety of settings such as traffic
accidents, accidents in professional and recreational con-
texts, falls, arson, but also self-inflicted injury (including
suicide) and injuries resulting from interpersonal violence
[68, 148, 149]. The assessment of causality is often diffi-
cult and needs triangulation by different sources, such as
time series analyses, natural experiments, case-control
studies, emergency-room studies, general population sur-
veys, and experimental designs [150]. The context of
drinking, social and cultural environment, and drinking
patterns, however, is probably as important as the amount
of alcohol consumed. To give an example, studies on vio-
lent incidents have repeatedly shown that alcohol con-
sumption precedes violent events and the amount of
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Table 4. Acute alcohol-related health effects with attributable fractions from international comparisons
Diseases ICD-9 De Bakey et al. [25]
USA
females males
English et al. [13]
Australia
females males
Single et al. [10]
Canada
females males
Gutjahr and Gmel [22]
Switzerland
females males
E810–E819 0.42 0.42 0.00–0.34 0.18–0.43 0.43 0.43 0.00–0.34 0.18–0.42
Non-traffic accident injuries E820–E825 0.42 0.42 0.00–0.34 0.18–0.43 0.43 0.43 0.00–0.34 0.18–0.42
Bicycle accident injuries E826 0.20 0.20 0.00–0.34 0.18–0.43 0.20 0.20 0.00–0.34 0.18–0.42
Other road vehicle accident injuries E829 0.20 0.20 0.00–0.34 0.18–0.43 0.2 0.20 0.00–0.34 0.18–0.42
Water transport accident injuries E830–E839 0.20 0.20 * * 0.20 0.20 0.20 0.20
Air-space transport accident injuries E840–E845 0.16 0.16 * * 0.16 0.16 0.16 0.16
Accidental ethanol and methanol poisoning E860.0–E860.2 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.10
Accidental fall injuries E880–E888 0.35 0.35 0.34 0.34 0.13–0.34 0.20–0.34 0.13–0.34 0.20–0.34
Arson injuries E890–E899 0.45 0.45 0.44 0.44 0.38 0.38 0.38 0.38
Accidental excessive cold E901 0.25 0.25 * * 0.25 0.25 0.25 0.25
Accidental drowning E910 0.38 0.38 0.03–0.50 0.03–0.50 0.01–0.50 0.01–0.50 0.01–0.38 0.01–0.38
Accidental aspiration E911 0.25 0.25 1.00 1.00 0.25 0.25 0.25 0.25
Striking against/struck by objects E917 0.25 0.25 * * 0.07 0.07 0.07 0.07
Caught in/between objects E918 0.25 0.25 * * 0.07 0.07 0.07 0.07
Occupational and machine injuries E919–E920 0.25 0.25 0.07 0.07 0.07 0.07 0.07 0.07
Accidental firearm missile injuries E922 0.25 0.25 * * 0.25 0.25 0.25 0.25
Suicide, self-inflicted injuries E950–E959 0.28 0.28 0.02–0.10 0.02–0.15 0.11–0.19 0.23–0.31 0.02–0.10 0.02–0.15
Victim, fight, brawl, rape E960 0.46 0.46 0.47 0.47 0.27 0.27 0.27 0.27
Victim assault firearms E965 0.46 0.46 0.47 0.47 0.27 0.27 0.27 0.27
Victim assault cutting instrument E966 0.46 0.46 0.47 0.47 0.27 0.27 0.27 0.27
Victim child battering E967 0.46 0.46 0.16 0.16 0.16 0.16 0.16 0.16
Victim assault other E968 0.46 0.46 0.47 0.47 0.27 0.27 0.27 0.27
Late effects of injuries by another E969 0.46 0.46 0.47 0.47 0.27 0.27 0.27 0.27
Ranges refer to age-specific attributable fractions whereby minimum and maximum estimates are shown.
* No AAFs provided by the authors.
drinking is related to the severity of subsequent violence,
pointing to causality in standard epidemiological terms
[151]. The bar atmosphere, expectancies of alcohol ef-
fects, and the social and cultural environment ‘permit-
ting’ alcohol to disinhibit norms are highly important [6,
19] to alcohol becoming a ‘cause’ of violent events. Over-
all, in the literature on alcohol-related mortality and mor-
bidity, there is a broad consensus that alcohol plays a cau-
sal role in the events summarized in table 4.
Although some causal role of alcohol for acute conse-
quences can be assumed, some very important method-
ological issues need to be clarified when it comes to quan-
tifying the fractions of consequences attributed to alcohol
[152]. For example, accidents are often attributed to alco-
hol whenever the responsible individual tested BAC-posi-
tive. However, from a strict epidemiological point of
view, blood or breath tests can give only an indication of
an association; since it cannot be determined how many
such accidents would have happened even without drink-
ing, it is virtually impossible to determine precisely the
role of alcohol in these events [21, 153]. Clearly, in
reviews of experimental studies [154, 155] psychophysical
functions showed deficits already at BAC levels of about
0.03–0.05 g/100 ml and deficits increased with increasing
levels which explained the mechanism of alcohol contri-
bution for accidents. However, an elevated BAC level
alone is not a sufficient indicator for alcohol being the
cause of an accident, and hence AAFs determined by
BAC thresholds are usually biased.
Discussion
The present paper is aimed at summarizing and updat-
ing the available evidence on alcohol-related consequences
and the quantification of the alcohol attribution of estab-
lished consequences. Of course, the list of established con-
ditions presented here is not a definitive list of alcohol-
related consequences. Rather, it should be regularly up-
dated in the light of ongoing research and the appearance
of new evidence. Biological evidence plays a key role here,
as some of the consistent associations between alcohol and
disease are currently refused because of the lack of biologi-
cal plausibility (e.g. alcohol and lung cancer).
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Besides establishing causality, the quantification of the
AAF is at least of equal importance for the estimation of
alcohol-related burden. For consequences, which are as-
sumed to be stable across cultures and related mainly to
total volume of consumption, the pooling of studies pri-
marily needs comparable exposure levels (besides quality
of research design and publishing of relevant statistics)
[115]. Studies, however, often differ greatly with respect
to assessment of exposure. For example, levels depicted as
a moderate intake often are not comparable. Standardiza-
tion of exposure levels, e.g. those used by English et al.
[13], would further help meta-analytical reviews and more
stable estimation of RRs.
For many of the alcohol-related consequences, sub-
stantial evidence has been accumulated that patterns of
drinking are equally important as predictors of both
chronic and acute health outcomes [4, 5, 121, 156]. For
example, cardiovascular disease as a chronic outcome is
also influenced by the pattern of drinking [4, 157]. Thus,
an investigation by McElduff and Dobson [120] showed
that a pattern of moderate regular drinking was associated
with a reduction in risk of CHD when compared to
abstainers, whereas binge drinkers displayed an increased
risk. Similarly Walsh and Rehm [158] showed for a range
of consequences that the same amount of alcohol was
more detrimental when drank in a more irregular man-
ner.
The impact of drinking patterns on the risk of conse-
quences, as well as the protective effect for some conse-
quences at lower levels, raises the question of the counter-
factual scenario to calculate AAFs. Commonly, absten-
tion is used as counterfactual. Hence, the alcohol-attribut-
able burden estimated by means of AAF and calculated
under this scenario estimates the burden that could be
avoided if everybody in a population switched to no con-
sumption at all. Such a scenario widely avoids arguments
about whether drinking patterns should be included in
determining the RRs as all drinking would disappear. The
avoidable burden from patterns of drinking would be
attributed to the respective categories of volume of drink-
ing [see the recent literature about refining the preventive
paradox, e.g. 159, 160].
The usefulness of abstinence as the counterfactual (or
the theoretical minimum) [3], on the other hand, can be
questioned on several grounds. First, total abstinence of a
population is an unrealistic scenario for most countries in
the world (maybe with the exception of some countries
where abstinence and prohibition are religiously moti-
vated). Hence, from a public health point of view absti-
nence may be difficult to communicate in most countries,
especially as the preventive message of moderate con-
sumption for the heart has reached a wide audience [161].
Second, abstinence as a counterfactual would also under-
estimate the avoidable burden at least in established mar-
ket economies, as the ‘prevented’ burden would partly
counterbalance the ‘caused’ burden. In countries in which
the prevention of CHD plays a minor role, however, prob-
ably more burden would be avoided with abstinence as
the counterfactual compared with, e.g., moderate con-
sumption as the counterfactual [103].
On the other hand, the use of a moderate volume of
drinking as a counterfactual scenario [13] is also question-
able. First, as drinking patterns modify the association
between the volume of drinking and health consequences
[3], a counterfactual scenario defined by volume only
would underestimate the avoidable burden. Second, some
acute consequences (e.g. accidents) have higher risks even
at moderate levels of consumption and the question is not
whether an individual should be abstinent or a moderate
consumer, but whether he or she should abstain in certain
risky situations. Other acute consequences are more close-
ly related to heavy occasional drinking than volume of
drinking as well as to environmental and socio-cultural
factors [20].
To summarize, a single counterfactual scenario may
not be equally well applicable to all consequences and in
all cultures. In addition to modeling the attributable bur-
den as deviation from abstinence, different scenarios
should be integrated and sensitivity analyses should be
performed.
However, without sufficient data such discussions are
mainly theoretical and do not lead to any solutions. The
use of patterns of drinking in epidemiological research is
still scarce, and focus is often placed on the (average) vol-
ume of drinking only [162]. To integrate patterns of
drinking in a comparative risk assessment, worldwide
standardized measures of exposure, including volume
and patterns of drinking, are urgently needed. Moreover,
the proportion of mortality and morbidity stemming from
acute consequences is at least as important as that from
chronic consequences, not only in young people [9]. With
the exception of some countries (mainly the Scandinavian
countries, Canada, USA, Australia), for which the share of
the global burden of disease is small in comparison to
countries such as China, India, or Brazil, data and esti-
mates on AAFs for acute problems are rare. Therefore
AAFs from other countries are often applied to those
countries for which data are lacking, despite the knowl-
edge that the cultural environment is of particular impor-
tance for such consequences.
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In conclusion, research on alcohol-related health out-
comes at present not only needs to take into consideration
both the average (volume) consumption and patterns of
drinking and to standardize the assessment of exposure, it
also needs to conduct studies on those outcomes which
are culturally co-determined to a large extent, especially
in developing and emerging countries.
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